Croatian biotech vitaLABS advances VB-7 anti-aging drug for dogs

Zagreb-based vitaLABS is developing VB-7, a molecule aimed at healthier aging in dogs, with formulations at the core of the project. The development is at an early stage, with no clinical data or timeline disclosed. This is a niche veterinary biotech development with limited immediate market or geopolitical impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works